and was funded by Pfizer Inc. The authors would also like to acknowledge the contributions of Raluca Pascu, PharmD, to the conduct of these studies.

Authors' contributions {#FPar1}
======================

AI contributed to data acquisition and to the writing of the manuscript, and approved the final version of the manuscript. JP contributed to data acquisition and to the writing of the manuscript, and approved the final version of the manuscript. KB participated in study coordination and conduct, was the clinical lead on Study 3003, helped with drafting and revising of the manuscript, and read and approved the final manuscript. KL contributed to the design of the bapineuzumab extension trials and served as a medical monitor for these studies, and participated in data interpretation and drafting and reviewing of the manuscript. GL wroteKenda Lenseigne

Accomplished Horsewoman, Sharpshooter, Entrepreneur.

Kenda has spent her life on the back of a horse. She started competing at the ripe old age of four and continued all throughout her childhood in both Western and English disciplines. After an apprenticeship in Texas with some of the country’s top cutting horse trainers, she was introduced to the sport of mounted shooting in California, where she qualified for the World Championship after only her 4th competition.

Since those early days, she’s developed a reputation as an accomplished trainer of both horses and people, won just about everything there is to win in the competitive arena and cultivated a thriving business dedicated to introducing others to her sport.

Her proudest accomplishment remains winning the title of Overall World Champion, becoming the first woman